EUVIMEDEUVIMED entdecken
Übersichtsarbeit

Age-Related Considerations in Cardio-Oncology

Elles M Screever iD, Wouter C Meijers, Javid J Moslehi

Journal of Cardiovascular Pharmacology and Therapeutics · 2021-03 · 26 (2) · 103-113

DOI: 10.1177/1074248420968689 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Journal of Cardiovascular Pharmacology and Therapeutics, online erschienen am 30.10.2020. Verfasst von Elles M Screever und 2 weiteren Autor:innen. Beteiligte Einrichtung: Department of Medicine, 12328Vanderbilt University Medical Center, Nashville, TN, USA. Hauptthemen laut MEDLINE: Cardiotoxicity. Die Arbeit wurde bisher 24-mal zitiert (Crossref) und nennt 114 Literaturangaben. Gefördert von: National Institute of Health, national institutes of health.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Cardio-Oncology has blossomed as a new field in cardiovascular medicine, in large part due to new therapies, which may have cardiovascular sequelae. Despite this, anthracyclines still serve as cornerstone therapy for most pediatric cancers, several solid tumors and hematological malignancies. Cardiotoxicity is the main limiting concern with anthracyclines, and this is particularly an issue in patients in extremes of age (both young and old patients). Pediatric hearts are susceptible for cardiotoxicity, while in older patients, concomitant risk factors may contribute to lower threshold for cardiotoxic effects. With increasing patient survival, a significant increase in elderly cancer patients and long-term cardiotoxicity effects of anthracyclines, a better mechanistic understanding of age-dependent processes—that define cardiotoxicity—is needed. This review sheds light on how age affects underlying molecular pathways of anthracycline-associated cardiotoxicity and aims to provide preventive strategies that can be used in clinical practice.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

CardiotoxicityAge FactorsAnthracyclinesCardiologyCardiovascular DiseasesHumansMedical OncologyRisk Factors

Stichwörter der Autor:innen

anthracyclinescardio-oncologycardiotoxicityelderlypediatric

Substanzen

Anthracyclines

Autor:innen und Institutionen

  • Department of Medicine, 12328Vanderbilt University Medical Center, Nashville, TN, USA.

ORCID-Profile: Elles M Screever

Förderung

  • National Institute of Health
  • national institutes of health

Zitieren

APA

Screever, E. M., Meijers, W. C., & Moslehi, J. J. (2021). Age-Related Considerations in Cardio-Oncology. Journal of Cardiovascular Pharmacology and Therapeutics, 26(2), 103-113. https://doi.org/10.1177/1074248420968689

Vancouver

Screever EM, Meijers WC, Moslehi JJ. Age-Related Considerations in Cardio-Oncology. Journal of Cardiovascular Pharmacology and Therapeutics. 2021;26(2):103-113. doi:10.1177/1074248420968689

BibTeX
@article{Screever2021,
  author = {Screever, Elles M and Meijers, Wouter C and Moslehi, Javid J},
  title = {Age-Related Considerations in Cardio-Oncology},
  journal = {Journal of Cardiovascular Pharmacology and Therapeutics},
  year = {2021},
  volume = {26},
  number = {2},
  pages = {103--113},
  doi = {10.1177/1074248420968689}
}
Kostenlos starten →